{"title":"GLP-1s among most effective in reducing weight in antipsychotic-treated patients","authors":"","doi":"10.1002/pu.31510","DOIUrl":null,"url":null,"abstract":"<p>A systematic review and network meta-analysis encompassing 95 studies has found considerable variation among pharmacological interventions to reduce weight in antipsychotic-treated patients with schizophrenia. The glucagon-like peptide-1 (GLP-1) receptor agonists semaglutide, liraglutide, and exenatide were among the medications found to be associated with the greatest weight reduction with the highest-certainty evidence.</p>","PeriodicalId":22275,"journal":{"name":"The Brown University Psychopharmacology Update","volume":"37 11","pages":"3-4"},"PeriodicalIF":0.0000,"publicationDate":"2026-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Brown University Psychopharmacology Update","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/pu.31510","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
A systematic review and network meta-analysis encompassing 95 studies has found considerable variation among pharmacological interventions to reduce weight in antipsychotic-treated patients with schizophrenia. The glucagon-like peptide-1 (GLP-1) receptor agonists semaglutide, liraglutide, and exenatide were among the medications found to be associated with the greatest weight reduction with the highest-certainty evidence.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
